Dexamethasone Downregulates Calcification-Inhibitor Molecules and Accelerates Osteogenic Differentiation of Vascular Pericytes
- 26 May 2006
- journal article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 98 (10) , 1264-1272
- https://doi.org/10.1161/01.res.0000223056.68892.8b
Abstract
Vascular calcification is present in many pathological conditions and is recognized as a strong predictor of future cardiovascular events. Current evidence suggests that it is a regulated process involving inducing and inhibitory molecules. Glucocorticoids have great clinical importance as antiinflammatory drugs and can act as potent inducers of osteogenic differentiation in vitro. The effect of glucocorticoids on vascular cells in vivo remains obscure. Pericytes are pluripotent cells that can differentiate into osteoblasts, and recent evidence suggests that they could participate in vascular calcification. We hypothesized that the synthetic glucocorticoid dexamethasone would enhance the rate of pericyte differentiation and mineralization in vitro with a concomitant suppression of calcification-inhibitory molecules. Three weeks of dexamethasone treatment induced a 2-fold increase in (1) alkaline phosphatase activity, (2) calcium deposition, and (3) the number of nodules formed in vitro; and a reduction in the expression of matrix Gla protein (MGP), osteopontin (OPN), and vascular calcification-associated factor (VCAF) mRNAs. The glucocorticoid receptor antagonist Org 34116 abolished dexamethasone-accelerated pericyte differentiation, nodule formation, and mineralization. Data obtained using Org 34116, the transcription inhibitor actinomycin D, and the protein synthesis inhibitor cyclohexamide suggest that MGP, OPN, and VCAF mRNA abundance are controlled at different and multiple levels by dexamethasone. This is the first report showing that dexamethasone enhances the osteogenic differentiation of pericytes and downregulates genes associated with inhibition of mineralization. Our study highlights the need for further investigation into the long-term consequences of prolonged glucocorticoid therapy on vascular calcification.Keywords
This publication has 35 references indexed in Scilit:
- Identification and Characterization of Vascular Calcification–Associated Factor, a Novel Gene Upregulated During Vascular Calcification In Vitro and In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Spatial and Temporal Changes in the Subcellular Localization of the Nuclear Protein–Tyrosine Kinase, c-FesDNA and Cell Biology, 2005
- Multilineage Potential of Cells From the Artery WallCirculation, 2003
- Mouse embryo‐derived NIH3T3 fibroblasts adopt an osteoblast‐like phenotype when treated with 1α,25‐dihydroxyvitamin D3 and dexamethasone in vitroJournal of Cellular Physiology, 2002
- Matrix Gla protein is differentially expressed during the deposition of a calcified matrix by vascular pericytesFEBS Letters, 2000
- Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactionsOncogene, 2000
- Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA proteinNature, 1997
- Efficacy and safety ofdigoxin alone and in combination with low-dosediltiazem orbetaxolol to control ventricular rate in chronic atrial fibrillationThe American Journal of Cardiology, 1995
- Effect of degenerative spinal and aortic calcification on bone density measurements in post‐menopausal women: links between osteoporosis and cardiovascular disease?European Journal of Clinical Investigation, 1994
- TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify.Journal of Clinical Investigation, 1994